MFS Intermediate High Income Fund (CIF) Stock Chart & Stock Price History → Amazon's betting big on this unknown AI company (From Manward Press) (Ad) Free CIF Stock Alerts $1.70 +0.01 (+0.59%) (As of 05/15/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsDividendFinancialsOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendFinancialsOwnershipSEC FilingsShort InterestSocial Media MFS Intermediate High Income Fund Stock Price Performance5 Day Performance-0.29%1 Month Performance+3.99%3 Month Performance-0.88%6 Month Performance+4.14%Year-To-Date Performance-1.45%1 Year Performance+5.94% Receive CIF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MFS Intermediate High Income Fund and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsTiny AI projects with huge promise hiding in plain sight …I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars.Click here to find out who they are. CIF Stock Chart for Thursday, May, 16, 2024 CIF Chart by TradingView MFS Intermediate High Income Fund Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/15/2024$1.69$1.70+0.59%$1.71$1.6941,942 shs$32.07 million05/14/2024$1.71$1.69-1.46%$1.70$1.6814,636 shs$31.88 million05/13/2024$1.70$1.71+0.59%$1.73$1.7041,971 shs$32.35 million05/10/2024$1.71$1.70-0.88%$1.72$1.6956,932 shs$32.07 million05/09/2024$1.70$1.71+0.59%$1.71$1.6925,848 shs$32.35 million05/08/2024$1.71$1.70-0.29%$1.71$1.6933,069 shs$32.16 million Get the Latest News and Ratings for CIF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MFS Intermediate High Income Fund and its competitors with MarketBeat's FREE daily newsletter. 05/07/2024$1.70$1.71+0.24%$1.71$1.709,842 shs$32.26 million05/06/2024$1.70$1.70+0.06%$1.71$1.6878,917 shs$32.18 million05/03/2024$1.68$1.70+1.13%$1.70$1.6872,816 shs$32.16 million05/02/2024$1.68$1.68+0.06%$1.69$1.6828,432 shs$31.81 million05/01/2024$1.66$1.68+0.98%$1.68$1.6637,063 shs$31.79 million04/30/2024$1.67$1.66-0.38%$1.68$1.6658,973 shs$31.48 million04/29/2024$1.66$1.67+0.60%$1.68$1.6559,672 shs$31.60 million04/26/2024$1.65$1.66+0.61%$1.67$1.6559,210 shs$31.41 million04/25/2024$1.66$1.65-0.60%$1.66$1.6436,920 shs$31.22 million04/24/2024$1.66$1.66$1.67$1.6517,251 shs$31.41 million04/23/2024$1.67$1.66-0.60%$1.67$1.6584,130 shs$31.41 million04/22/2024$1.64$1.67+1.54%$1.67$1.6534,523 shs$31.60 million04/19/2024$1.64$1.64$1.65$1.6415,845 shs$31.03 million04/18/2024$1.63$1.64+0.61%$1.65$1.6386,725 shs$31.03 million04/17/2024$1.63$1.63$1.65$1.6263,803 shs$30.84 million04/16/2024$1.65$1.63-1.21%$1.66$1.6321,168 shs$30.84 million04/15/2024$1.67$1.65-1.20%$1.69$1.6561,606 shs$31.22 million04/12/2024$1.69$1.68-0.59%$1.70$1.6733,239 shs$31.79 million04/11/2024$1.69$1.69$1.69$1.6817,068 shs$31.98 million04/10/2024$1.70$1.69-0.59%$1.71$1.6953,311 shs$31.98 million04/09/2024$1.70$1.70-0.23%$1.71$1.7073,147 shs$32.16 million04/08/2024$1.71$1.70-0.06%$1.72$1.7019,665 shs$32.24 million04/05/2024$1.70$1.71+0.29%$1.71$1.7016,466 shs$32.26 million04/04/2024$1.70$1.70$1.71$1.6952,354 shs$32.16 million04/03/2024$1.70$1.70$1.71$1.7038,403 shs$32.16 million04/02/2024$1.71$1.70-0.58%$1.72$1.7012,462 shs$32.16 million04/01/2024$1.73$1.71-0.87%$1.73$1.71112,308 shs$32.35 million03/29/2024$1.73$1.73$1.73$1.7137,897 shs$32.64 million03/28/2024$1.72$1.73+0.29%$1.73$1.7137,866 shs$32.64 million03/27/2024$1.71$1.72+0.58%$1.73$1.7212,343 shs$32.54 million03/26/2024$1.71$1.71$1.72$1.7126,656 shs$32.36 million03/25/2024$1.71$1.71$1.73$1.7046,297 shs$32.35 million03/22/2024$1.72$1.71-0.58%$1.72$1.7089,016 shs$32.35 million03/21/2024$1.72$1.72+0.01%$1.73$1.7234,786 shs$32.54 millionThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)Nanoviricides Technology Will Transform The Way Viruses & Their Variants Are Treated Worldwide And This Company Is At The Forefront!See how with its ongoing expansion and development03/20/2024$1.71$1.72+0.58%$1.72$1.7211,026 shs$32.54 million03/19/2024$1.72$1.71-0.58%$1.72$1.715,868 shs$32.35 million03/18/2024$1.71$1.72+0.58%$1.72$1.7031,396 shs$32.54 million03/15/2024$1.72$1.71-0.58%$1.72$1.7014,612 shs$32.35 million03/14/2024$1.72$1.72$1.72$1.7055,993 shs$32.54 million03/13/2024$1.71$1.72+0.58%$1.73$1.7127,828 shs$32.54 million03/12/2024$1.72$1.71-0.29%$1.72$1.7022,406 shs$32.36 million03/11/2024$1.72$1.72-0.29%$1.72$1.7130,713 shs$32.45 million03/08/2024$1.72$1.72+0.03%$1.73$1.7132,558 shs$32.54 million03/07/2024$1.73$1.72-0.32%$1.74$1.7146,148 shs$32.53 million03/06/2024$1.73$1.73-0.29%$1.73$1.7149,694 shs$32.64 million03/05/2024$1.72$1.73+0.87%$1.74$1.71103,329 shs$32.73 million03/04/2024$1.73$1.72-0.87%$1.74$1.7129,346 shs$32.45 million03/01/2024$1.73$1.73$1.73$1.7229,440 shs$32.73 million02/29/2024$1.72$1.73+0.87%$1.73$1.7156,603 shs$32.73 million02/28/2024$1.71$1.72+0.29%$1.72$1.719,850 shs$32.45 million02/27/2024$1.69$1.71+1.18%$1.72$1.7055,355 shs$32.36 million02/26/2024$1.70$1.69-0.59%$1.71$1.6943,305 shs$31.98 million02/23/2024$1.70$1.70$1.72$1.7038,348 shs$32.16 million02/22/2024$1.71$1.70-0.58%$1.72$1.7034,478 shs$32.16 million02/21/2024$1.71$1.71-0.01%$1.72$1.7031,955 shs$32.35 million02/20/2024$1.71$1.71$1.72$1.7027,789 shs$32.35 million02/19/2024$1.71$1.71$1.73$1.7137,700 shs$32.35 million02/16/2024$1.72$1.71-0.58%$1.73$1.7137,755 shs$32.35 million02/15/2024$1.72$1.72$1.73$1.7237,730 shs$32.54 million Related Companies: NOM Stock Price Chart EQS Stock Price Chart CUBA Stock Price Chart EEA Stock Price Chart CEE Stock Price Chart GCV Stock Price Chart CEV Stock Price Chart DTF Stock Price Chart JEQ Stock Price Chart NXC Stock Price Chart Receive CIF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MFS Intermediate High Income Fund and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:CIF) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MFS Intermediate High Income Fund Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.